Plain-English translation of NCT02432092 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study aims to find the genetic causes of cardiomyopathy—a heart muscle disorder that affects children. Researchers will analyze blood samples from children who have been diagnosed with cardiomyopathy and from their family members to identify which genes are responsible for the disease. Understanding the genetic basis of this condition could help doctors provide better care and develop new treatments in the future.
While doctors have made progress in identifying genetic causes of heart muscle disease in adults, children's cases have proven harder to diagnose using current methods. This study exists because knowing exactly which genetic change caused a child's heart disease can help doctors predict how the disease will progress and create personalized treatment plans.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be asked to provide a blood sample that researchers will use to look for genetic mutations. Your family members may also be invited to participate and provide their own samples. The study is observational, meaning researchers are gathering information rather than testing a new medication—your participation involves a one-time or occasional visit to give blood and share medical information about your family's health history.
AI-generated summary from trial data · Jun 26, 2026 · Not medical advice
United States
Collaborators
American Heart Association
Enrollment target
~300 participants
Started
April 2014
Primary completion
December 2030
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Sarah Murphy, MPH
IU School of Medicine
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.